Literature DB >> 19702498

Multinutrient supplement as treatment: literature review and case report of a 12-year-old boy with bipolar disorder.

Elisabeth A Frazier1, Mary A Fristad, L Eugene Arnold.   

Abstract

Early-onset bipolar disorder has significant morbidity and mortality. Development of safe, effective treatments to which patients will adhere is critical. Pharmacologic interventions for childhood bipolar spectrum disorders are limited and are associated with significant risk for adverse events. Diet and nutrition research suggests vitamins, minerals, and other nutrients are important underpinnings of general physical and mental health; furthermore, they may even be useful in treating mood dysregulation by providing a more favorable risk-benefit ratio than contemporary psychotropic agents. This article reviews the literature on multinutrient supplementation and mental health, and examines a case study of a 12-year-old boy with bipolar disorder and co-morbid diagnoses treated for 6 years with conventional medication and finally a multinutrient supplement. The multinutrient supplement in this case study is EMPowerplus (EMP+), a 36-ingredient supplement containing 16 minerals, 14 vitamins, 3 amino acids, and 3 antioxidants. It was used to treat a 12-year-old boy initially diagnosed with bipolar disorder not otherwise specified (BP-NOS) at age 6, and whose diagnosis evolved by age 10 to bipolar I (BP-I), mixed, with psychotic features. He also met criteria for generalized anxiety disorder by age 8 and obsessive-compulsive disorder by age 10. After 6 years of conventional treatment (ages 6-12), he received 14 months of EMP+. Symptom manifestation over 7 years is described in conjunction with treatment history. EMP+ resulted in outcome superior to conventional treatment. This report adds to accumulating preliminary evidence that further basic science and clinical studies of multinutrient supplements are warranted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19702498     DOI: 10.1089/cap.2008.0157

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  10 in total

Review 1.  Preventative strategies for early-onset bipolar disorder: towards a clinical staging model.

Authors:  Robert K McNamara; Jayasree J Nandagopal; Stephen M Strakowski; Melissa P DelBello
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

2.  Open-label uridine for treatment of depressed adolescents with bipolar disorder.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Delmastro; Eun-Kee Jeong; Namkug Kim; Xianfeng Shi; Perry F Renshaw
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-12       Impact factor: 2.576

3.  Efficacy and cost of micronutrient treatment of childhood psychosis.

Authors:  Megan Rodway; Annette Vance; Amany Watters; Helen Lee; Elske Bos; Bonnie J Kaplan
Journal:  BMJ Case Rep       Date:  2012-11-09

4.  Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study.

Authors:  Heather A Gordon; Julia J Rucklidge; Neville M Blampied; Jeanette M Johnstone
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-12       Impact factor: 2.576

5.  Micronutrients versus standard medication management in autism: a naturalistic case-control study.

Authors:  Lewis Mehl-Madrona; Brenda Leung; Carla Kennedy; Sarah Paul; Bonnie J Kaplan
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-04       Impact factor: 2.576

6.  Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.

Authors:  Julia J Rucklidge; Dermot Gately; Bonnie J Kaplan
Journal:  BMC Psychiatry       Date:  2010-09-28       Impact factor: 3.630

7.  Future directions for research on youth with bipolar spectrum disorders.

Authors:  Mary A Fristad; Guillermo Perez Algorta
Journal:  J Clin Child Adolesc Psychol       Date:  2013-08-05

8.  Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders.

Authors:  Elisabeth A Frazier; Barbara Gracious; L Eugene Arnold; Mark Failla; Chureeporn Chitchumroonchokchai; Diane Habash; Mary A Fristad
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-10       Impact factor: 2.576

9.  Systematic review of safety and tolerability of a complex micronutrient formula used in mental health.

Authors:  J Steven A Simpson; Susan G Crawford; Estelle T Goldstein; Catherine Field; Ellen Burgess; Bonnie J Kaplan
Journal:  BMC Psychiatry       Date:  2011-04-18       Impact factor: 3.630

10.  Hospitalization cost of conventional psychiatric care compared to broad-spectrum micronutrient treatment: literature review and case study of adult psychosis.

Authors:  Bonnie J Kaplan; Wanrudee Isaranuwatchai; Jeffrey S Hoch
Journal:  Int J Ment Health Syst       Date:  2017-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.